Related Experiment Video
Updated: Jun 16, 2026
08:33
A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
Clinical trial: interferential electric stimulation in functional dyspepsia patients - a prospective randomized study
1Department of Gastroenterology, Ankara Education and Research Hospital, Ankara, Turkey. gskoklu@yahoo.com
Alimentary Pharmacology & Therapeutics
|February 9, 2010
Summary
Transcutaneous electrical stimulation using vacuum interferential current (IFC) effectively treats functional dyspepsia symptoms. This non-invasive therapy offers a new option for patients with drug-refractory functional dyspepsia.
Area of Science:
- Gastroenterology
- Medical Devices
- Neuromodulation
Background:
- Transcutaneous electrical stimulation (TES) shows promise for gastroparesis and chronic constipation.
- Functional dyspepsia (FD) is a common gastrointestinal disorder with limited treatment options.
Purpose of the Study:
- To evaluate the efficacy of vacuum interferential current (IFC) stimulation for functional dyspepsia.
- To compare IFC therapy against a placebo in FD patients.
Main Methods:
- Randomized controlled trial involving 44 functional dyspepsia patients.
- Intervention: 12 sessions of vacuum IFC over 4 weeks versus placebo.
- Symptom assessment at baseline, during, and after treatment.
Main Results:
- IFC therapy significantly improved epigastric discomfort, pyrosis, bloating, early satiation, and postprandial fullness compared to placebo.
- Improvements in early satiation and heartburn persisted one month post-treatment.
- No significant changes were observed in the placebo group for most symptoms.
Conclusions:
- Vacuum IFC is a non-invasive and effective treatment for functional dyspepsia.
- TES, specifically vacuum IFC, presents a novel therapeutic approach for drug-refractory FD.
- This modality may benefit patients unresponsive to conventional therapies.